Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Bladder cancer study
View:
Comment by Wino115 on Apr 28, 2022 10:39am
Very interesting find - thanks for sharing.  There's a lot of pertinent info.  We've been discussing this aspect and they reiterate what we had already understood to be the case on normal vs. cancer cells. "Previously, it has been reported that only 10% of total sortilin could translocate to the surface of normal cells while 90% remained in cytoplasmic organelles such as ...more  
Comment by SPCEO1 on Apr 28, 2022 11:11am
Thanks for reading that and pulling out the salient points for us. The new info here is that while the sortilin receptors are overexpressed on the surface in cancer cells, the interactions between TH-1902 and different types of cancer cells likely varies. That will make cracking the code of each type of cancer more difficult than if all cancer cells reacted similarly. But TH has the lead in this ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities